Upstream Bio Ratios (2023-2025) | UPB

Ratios Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 45.16%-177.65%-258.98%-350.24%-276.15%-967.24%-272.18%
EBT Margin -1,265.54%-2,846.89%-2,147.97%-2,875.10%-2,634.10%-3,465.25%-4,818.02%-4,259.98%-4,938.36%
EBIT Margin -1,511.43%-3,184.44%-2,345.78%-3,439.22%-3,112.52%-4,293.31%-5,656.01%-4,732.87%-5,539.39%
EBITDA Margin -1,511.43%-3,184.44%-2,345.78%-3,439.22%-3,112.52%-4,293.31%-5,656.01%-4,732.87%-5,539.39%
Operating Margin -1,511.43%-3,184.44%-2,345.78%-3,439.22%-3,112.52%-4,293.31%-5,656.01%-4,732.87%-5,539.39%
Net Margin -1,006.92%-3,329.78%-2,189.06%-3,835.69%-3,465.07%-3,554.65%-4,818.02%-4,265.31%-4,941.14%
FCF Margin -3,580.00%-2,744.06%-1,575.69%-2,300.16%-3,229.53%-7,272.97%-4,187.73%-3,265.59%
Efficiency
Assets Average 357.21M468.94M438.35M405.86M
Equity Average -117.67M-128.27M-140.01M-153.46M154.77M457.73M427.18M393.66M
Invested Capital -112.20M-123.13M-133.41M-146.61M-160.31M469.85M445.61M408.74M378.58M
Asset Utilization Ratio 0.010.000.010.01
Leverage & Solvency
Equity Ratio -1.05-0.690.980.980.970.97
Valuation
Enterprise Value -47.32M-109.81M-31.51M-47.34M1,227.52M410.68M-103.10M197.07M641.61M
Market Capitalization 1,448.18M881.13M328.28M590.65M1,014.04M
Return Ratios
Return on Sales -22.10%-25.92%-27.70%-34.48%-38.35%-43.64%
Return on Capital Employed -0.22%-0.21%-0.28%-0.36%
Return on Assets -0.18%-0.17%-0.24%-0.30%
Return on Equity 0.35%0.37%-0.42%-0.17%-0.24%-0.31%